PER 13.0% 13.0¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-78

  1. 13,462 Posts.
    lightbulb Created with Sketch. 1443
    There You go again Akki:
    of course it was a “Woe “ for Sarepta
    Leaked: that’s why Sarepta’s share price dropped when they made a positive announcement the other day re DMD….
    Sarepta was depending on good news soon fron
    Lysogene……Could be that they see a better result investing in Anp
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.015(13.0%)
Mkt cap ! $117.2M
Open High Low Value Volume
12.0¢ 13.5¢ 12.0¢ $612.7K 4.843M

Buyers (Bids)

No. Vol. Price($)
2 56662 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 600000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.